Intranasal Polymeric and Lipid-Based Nanocarriers for CNS Drug Delivery
Nanomedicine is currently focused on the design and development of nanocarriers that enhance drug delivery to the brain to address unmet clinical needs for treating neuropsychiatric disorders and neurological diseases. Polymer and lipid-based drug carriers are advantageous for delivery to the centra...
Main Authors: | Rebecca Maher, Almudena Moreno-Borrallo, Dhruvi Jindal, Binh T. Mai, Eduardo Ruiz-Hernandez, Andrew Harkin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/3/746 |
Similar Items
-
Mixed Amphiphilic Polymeric Nanoparticles of Chitosan, Poly(vinyl alcohol) and Poly(methyl methacrylate) for Intranasal Drug Delivery: A Preliminary In Vivo Study
by: Inbar Schlachet, et al.
Published: (2020-09-01) -
The Role of Natural Compounds and their Nanocarriers in the Treatment of CNS Inflammation
by: Bikram Khadka, et al.
Published: (2020-10-01) -
Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein
by: Luo Jian, et al.
Published: (2012-11-01) -
Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols
by: Wafaa Alabsi, et al.
Published: (2022-09-01) -
Potential of Lipid-Based Nanocarriers against Two Major Barriers to Drug Delivery—Skin and Blood–Brain Barrier
by: Mohammad Sameer Khan, et al.
Published: (2023-03-01)